| 名稱(chēng) | c-Kit A502_Y503dup/BaF3 |
| 型號(hào) | CBP73296 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | c-Kit A502_Y503dup/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO；ABL1，ABL 原癌基因 1，非受體酪氨酸激酶，通過(guò) ERK5、Rac/JNK 和 Stat1/3 通路在細(xì)胞生長(zhǎng)調(diào)節(jié)中發(fā)揮作用。已經(jīng)在各種癌癥中報(bào)道了 BCR-ABL1 融合蛋白導(dǎo)致組成型激酶活性，并且已經(jīng)證明 BCR-ABL1 背景下的許多 Abl1 突變會(huì)產(chǎn)生耐藥性。 |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 聚焦靶點(diǎn)BRAF——BRAF相關(guān)突變細(xì)胞強(qiáng)勢(shì)登場(chǎng)
- LTβR信號(hào)通路誘導(dǎo)三級(jí)淋巴結(jié)構(gòu)的形成，促進(jìn)趨化因子的表達(dá)
- 中國(guó)細(xì)胞資源庫(kù)，南京科佰生物
- 【產(chǎn)品推介】MSI標(biāo)準(zhǔn)品
- 甲基丙二酸血癥（MMA）標(biāo)準(zhǔn)品上新
- 喝熱茶或使食管癌風(fēng)險(xiǎn)增加5倍
- BCR-ABL激酶抑制劑細(xì)胞篩選模型
- 自身免疫疾病潛力靶點(diǎn)——IL-5藥篩細(xì)胞模型
- ATCC細(xì)胞株開(kāi)發(fā)的四階段簡(jiǎn)介
- 特定細(xì)胞株的培養(yǎng)條件怎么獲取到呢？
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73296c-Kit A502_Y503dup/BaF3
- 詳細(xì)內(nèi)容
| CBP73296 | |
| I. Introduction | |
Cell Line Name： | c-Kit A502_Y503dup/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II. Background | |
| KIT A502_Y503dup (also referred to as Y503_F504insAY) indicates the insertion of 2 duplicate amino acids, alanine (A)-502 through tyrosine (Y)-503, in the Ig-like C2-type domain 5 (exon 9) of the Kit protein . A502_Y503dup results in constitutive phosphorylation of Kit and is transforming in cell culture. | |
III. Representative Data | |
1. WB of c-Kit A502_Y503dup/BaF3
| |
2. Sanger of c-Kit A502_Y503dup/BaF3
| |
3. Anti-proliferation assay
Figure 4. CTG Proliferation Assay of BaF3 C-KIT A502_Y503dup Cells (C5). | |
會(huì)員_a.png)